3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry-MedSci.cn

3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry

Kuemmerle-Deschner, JB; Kortus-Goetze, B; Oommen, PT; Janda, A; Rech, J; Schuetz, C; Kallinich, T; Weller-Heinemann, F; Horneff, G; Foeldvari, I; Meier, F; Borte, M; Krickau, T; Weber-Arden, J; Blank, N

ARTHRITIS & RHEUMATOLOGY, 2022; 74 (): 1613

科室
- - 订阅+
  - 更多科室
工具
服务